- Home
- JSPR vs BLDE Comparison
JSPR vs BLDE Comparison
Compare JSPR & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- BLDE
- Stock Information
- Founded
- JSPR 2018
- BLDE 2014
- Country
- JSPR United States
- BLDE United States
- Employees
- JSPR N/A
- BLDE N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- BLDE Aerospace
- Sector
- JSPR Health Care
- BLDE Consumer Discretionary
- Exchange
- JSPR Nasdaq
- BLDE Nasdaq
- Market Cap
- JSPR 321.8M
- BLDE 276.7M
- IPO Year
- JSPR N/A
- BLDE N/A
- Fundamental
- Price
- JSPR $21.03
- BLDE $4.08
- Analyst Decision
- JSPR Strong Buy
- BLDE Buy
- Analyst Count
- JSPR 11
- BLDE 1
- Target Price
- JSPR $73.38
- BLDE $6.00
- AVG Volume (30 Days)
- JSPR 174.0K
- BLDE 1.5M
- Earning Date
- JSPR 11-07-2024
- BLDE 11-12-2024
- Dividend Yield
- JSPR N/A
- BLDE N/A
- EPS Growth
- JSPR N/A
- BLDE N/A
- EPS
- JSPR N/A
- BLDE N/A
- Revenue
- JSPR N/A
- BLDE $241,814,000.00
- Revenue This Year
- JSPR N/A
- BLDE $11.34
- Revenue Next Year
- JSPR N/A
- BLDE $5.73
- P/E Ratio
- JSPR N/A
- BLDE N/A
- Revenue Growth
- JSPR N/A
- BLDE 12.04
- 52 Week Low
- JSPR $5.00
- BLDE $2.45
- 52 Week High
- JSPR $31.01
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- JSPR 45.81
- BLDE 52.77
- Support Level
- JSPR $19.41
- BLDE $4.02
- Resistance Level
- JSPR $23.11
- BLDE $4.27
- Average True Range (ATR)
- JSPR 1.83
- BLDE 0.38
- MACD
- JSPR -0.21
- BLDE -0.05
- Stochastic Oscillator
- JSPR 24.40
- BLDE 17.97
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.